Breaking News1 year ago
Merck KGaA Enters Deal With BenevolentAI, Exscientia for AI-Based Drug Discovery
[ad_1] By David Sachs Merck KGaA said that it has partnered with BenevolentAI and Exscientia on an initiative to discover more drugs with artificial intelligence, which...
